Search
Bruker Corp
BRKRAdd to Watchlist
44.730USD
+1.460+3.37%
Close 05/12, 16:00（ET）Quotes delayed by 15 min
6.81BMarket Cap
LossP/E TTM
More Details of Bruker Corp Company
Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
Bruker Corp Info
Ticker SymbolBRKR
Company nameBruker Corp
IPO dateAug 04, 2000
CEOPrause (Burkhard A)
Number of employees11396
Security typeOrdinary Share
Fiscal year-endAug 04
Address40 Manning Rd
CityBILLERICA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01821-3915
Phone19786633660
Websitehttps://www.bruker.com/
Ticker SymbolBRKR
IPO dateAug 04, 2000
CEOPrause (Burkhard A)
Company Executives of Bruker Corp
Name
Name/Position
Position
Shareholding
Change
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.41M
-0.02%
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
89.17K
-1.37%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
84.15K
-13.33%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
56.19K
-24.79%
Mr. John A. Ornell, CPA
Mr. John A. Ornell, CPA
Independent Director
Independent Director
35.21K
-3.47%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
30.94K
-15.02%
Dr. Hermann Fritz Requardt, Ph.D.
Dr. Hermann Fritz Requardt, Ph.D.
Independent Director
Independent Director
26.45K
-4.62%
Ms. Adelene Q. Perkins
Ms. Adelene Q. Perkins
Independent Director
Independent Director
24.62K
-4.96%
Dr. Cynthia M. Friend, Ph.D.
Dr. Cynthia M. Friend, Ph.D.
Independent Director
Independent Director
18.02K
-6.78%
Ms. Bonnie H. Anderson
Ms. Bonnie H. Anderson
Independent Director
Independent Director
13.33K
-9.17%
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.41M
-0.02%
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
89.17K
-1.37%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
84.15K
-13.33%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
56.19K
-24.79%
Mr. John A. Ornell, CPA
Mr. John A. Ornell, CPA
Independent Director
Independent Director
35.21K
-3.47%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
30.94K
-15.02%
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Product
2.77B
80.50%
Product And Service Other
670.10M
19.50%
Service and other revenue
670.10M
19.50%
By RegionUSD
Name
Revenue
Proportion
Rest of Europe
950.20M
27.65%
United States
891.30M
25.94%
Rest of Asia Pacific
552.60M
16.08%
China
475.80M
13.85%
Germany
297.00M
8.64%
Other
269.60M
7.85%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product
2.77B
80.50%
Product And Service Other
670.10M
19.50%
Service and other revenue
670.10M
19.50%
Shareholding Stats
Updated: Mon, May 11
Updated: Mon, May 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Laukien (Frank H)
26.54%
Orbis Investment Management Ltd.
10.60%
Fidelity Management & Research Company LLC
8.45%
Pallas Capital Advisors LLC
6.23%
BlackRock Institutional Trust Company, N.A.
6.19%
Other
41.99%
Shareholders
Shareholders
Proportion
Laukien (Frank H)
26.54%
Orbis Investment Management Ltd.
10.60%
Fidelity Management & Research Company LLC
8.45%
Pallas Capital Advisors LLC
6.23%
BlackRock Institutional Trust Company, N.A.
6.19%
Other
41.99%
Shareholder Types
Shareholders
Proportion
Investment Advisor
50.84%
Investment Advisor/Hedge Fund
27.99%
Individual Investor
26.97%
Hedge Fund
8.83%
Research Firm
1.99%
Pension Fund
1.24%
Private Equity
0.37%
Bank and Trust
0.35%
Insurance Company
0.21%
Institutional Shareholding
Updated: Sun, Apr 5
Updated: Sun, Apr 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
929
139.65M
91.74%
-14.82M
2025Q4
887
137.27M
94.12%
+111.45K
2025Q3
908
137.16M
94.45%
+8.73M
2025Q2
904
127.18M
89.58%
+1.13M
2025Q1
886
125.13M
85.85%
-5.11M
2024Q4
855
125.47M
82.99%
+4.02M
2024Q3
812
120.93M
80.76%
+2.25M
2024Q2
782
118.65M
76.64%
+5.15M
2024Q1
766
113.09M
82.81%
-916.64K
2023Q4
748
112.27M
83.16%
-472.55K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Laukien (Frank H)
40.41M
26.55%
+31.93K
+0.08%
Aug 15, 2025
Orbis Investment Management Ltd.
16.13M
10.6%
+1.22M
+8.21%
Feb 28, 2026
Fidelity Management & Research Company LLC
12.87M
8.45%
+1.44M
+12.65%
Dec 31, 2025
Pallas Capital Advisors LLC
9.48M
6.23%
+114.00
+0.00%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
9.42M
6.19%
+199.52K
+2.16%
Dec 31, 2025
State Street Investment Management (US)
3.83M
2.52%
+91.71K
+2.45%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
3.19M
2.1%
-3.19M
-50.01%
Dec 31, 2025
Sculptor Capital Management, Inc
3.00M
1.97%
-74.80K
-2.43%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
First Trust NYSE Arca Biotechnology Index Fund
3.71%
ProShares Nanotechnology ETF
3.34%
State Street SPDR S&P Kensho Future Security ETF
1.27%
Ballast Small/Mid Cap ETF
1.13%
AB Disruptors ETF
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.61%
State Street SPDR S&P Kensho New Econ Comp ETF
0.57%
iShares Health Innovation Active ETF
0.4%
iShares Biotechnology ETF
0.36%
JPMorgan Active Small Cap Value ETF
0.31%
View more
First Trust NYSE Arca Biotechnology Index Fund
Proportion3.71%
ProShares Nanotechnology ETF
Proportion3.34%
State Street SPDR S&P Kensho Future Security ETF
Proportion1.27%
Ballast Small/Mid Cap ETF
Proportion1.13%
AB Disruptors ETF
Proportion0.63%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.61%
State Street SPDR S&P Kensho New Econ Comp ETF
Proportion0.57%
iShares Health Innovation Active ETF
Proportion0.4%
iShares Biotechnology ETF
Proportion0.36%
JPMorgan Active Small Cap Value ETF
Proportion0.31%
Dividend
A total of
113.60M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Mar 04, 2026
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Apr 07, 2026 going ex on Mar 23, 2026
Mar 23, 2026
Apr 07, 2026
Mar 23, 2026
Nov 04, 2025
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Jan 02, 2026 going ex on Dec 08, 2025
Dec 08, 2025
Jan 02, 2026
Dec 08, 2025
Aug 12, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Oct 03, 2025 going ex on Sep 23, 2025
Sep 23, 2025
Oct 03, 2025
Sep 23, 2025
May 15, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 27, 2025 going ex on Jun 16, 2025
Jun 16, 2025
Jun 27, 2025
Jun 16, 2025
Feb 21, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 28, 2025 going ex on Mar 17, 2025
Mar 17, 2025
Mar 28, 2025
Mar 17, 2025
Nov 18, 2024
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 16, 2024 going ex on Dec 02, 2024
Dec 02, 2024
Dec 16, 2024
Dec 02, 2024
Aug 14, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 16, 2024 going ex on Aug 30, 2024
Sep 02, 2024
Sep 16, 2024
Aug 30, 2024
May 15, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 17, 2024 going ex on Jun 03, 2024
Jun 03, 2024
Jun 17, 2024
Jun 03, 2024
Feb 16, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 20, 2023
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 15, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 15, 2023
Nov 30, 2023
View more
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
